Home / Health / New Weekly Insulin Jab Could Transform Diabetes Care
New Weekly Insulin Jab Could Transform Diabetes Care
20 Aug
Summary
- A new weekly jab may reduce yearly injections by 86%.
- Nice recommended the treatment, awaiting MHRA approval.
- It aims to ease daily management for type 2 diabetes patients.
A potential breakthrough in type 2 diabetes management is on the horizon with a new weekly insulin jab that could significantly reduce the number of injections required. Health officials are awaiting a ruling from the Medicines and Healthcare Products Regulatory Agency (MHRA) on the treatment, known as Onswik, which has been recommended by the National Institute for Health and Care Excellence (Nice).
If approved, this weekly jab could replace the need for 365 daily injections with just 52 per year, an 86% reduction. This change is expected to particularly benefit individuals who need help with injections, including those with visual impairments, limited hand mobility, or learning disabilities. It offers greater flexibility and could improve the quality of life for many patients.
Experts suggest that moving to a weekly regimen could provide more freedom in daily life and free up valuable time for both patients and healthcare providers. The treatment also aims to help patients manage their diabetes effectively, potentially preventing long-term complications. Diabetes UK emphasizes the importance of clear guidance and fair access should the treatment be rolled out on the NHS.
